Omnicare

Omnicare is a German distributor of medicinal products used for patient-specific production of cancer drugs.

Founded in 2002 and headquartered in Munich, Omnicare supplies specialised pharmacies with medicinal products required for the preparation of patient-specific cancer treatments. The company’s customer base primarily consists of compounding pharmacies serving oncology practices across Germany. 

In addition to its distribution activities, Omnicare offers selected support services to specialised pharmacies, including quality-related processes, hygiene monitoring and staff training. 

During Equistone’s investment period, Omnicare expanded through the acquisition of outpatient oncology medical centres, known as MVZs, broadening its exposure to oncology care provision in Germany.

THE EXIT

Equistone Fund VI sold its investment in Omnicare to Allianz ambulante Onkologie, an existing shareholder in the company.